idelalisib has been researched along with Neoplasm-Metastasis* in 1 studies
1 other study(ies) available for idelalisib and Neoplasm-Metastasis
Article | Year |
---|---|
Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species.
Topics: Animals; Antigens, CD20; Antineoplastic Agents; Humans; Immunosuppression Therapy; Killer Cells, Natural; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; NADPH Oxidase 2; Neoplasm Metastasis; Phosphoinositide-3 Kinase Inhibitors; Purines; Quinazolinones; Reactive Oxygen Species | 2020 |